Administration of a PGE2 receptor EP4-selective agonist increased TNF-α (an inflammatory cytokine) levels and exacerbated renal fibrosis in an animal model of type 1 diabetes (Mohamed et al., 2013). The gene discussed is TNF; the disease is renal fibrosis.